Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,157,721
+$7,682,602 QoQ
Shares Held
998,253
-0.3% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 193 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. GLUE ranks #103 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in GLUE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,157,721 | 998,253 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,475,119 | 1,001,527 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,639,366 | 295,878 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $749,476 | 101,144 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,570,417 | 348,208 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,652,359 | 356,112 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,109,524 | 159,874 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $946,606 | 178,605 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $345,384 | 92,349 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $111,136 | 15,764 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $210,055 | 37,178 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $259,665 | 54,210 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $310,551 | 45,336 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $251,094 | 32,233 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $334,550 | 43,962 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $272,011 | 33,294 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $387,920 | 40,116 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $698,433 | 49,817 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $709,513 | 34,746 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $425,971 | 19,119 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,462,950 | 108,500 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||